Wolverine Trading, LLC Aurinia Pharmaceuticals Inc. Call Options Transaction History

Wolverine Trading, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$4.93 - $9.31 $532,440 - $1.01 Million	-108,000 Reduced 57.54%	79,700 $399,000
Q4 2023 Feb 14, 2024	BUY	$7.13 - $9.49 $1.34 Million - $1.78 Million	187,700 New	187,700 $1.69 Million
Q2 2023 Aug 23, 2023	SELL	$8.96 - $11.69 $83,328 - $108,717	-9,300 Reduced 5.48%	160,300 $1.55 Million
Q1 2023 May 15, 2023	BUY	$5.94 - $11.27 $146,124 - $277,242	24,600 Added 16.97%	169,600 $1.86 Million
Q4 2022 Feb 14, 2023	BUY	$4.11 - $8.14 $595,950 - $1.18 Million	145,000 New	145,000 $626,000
Q2 2022 Aug 15, 2022	SELL	$8.95 - $12.8 $1.61 Million - $2.3 Million	-180,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$10.05 - $22.48 $21,105 - $47,208	-2,100 Reduced 1.15%	180,000 $2.23 Million
Q4 2021 Feb 14, 2022	SELL	$17.78 - $33.08 $64,008 - $119,088	-3,600 Reduced 1.94%	182,100 $4.15 Million
Q3 2021 Nov 12, 2021	BUY	$10.93 - $23.55 $2.03 Million - $4.37 Million	185,700 New	185,700 $4.27 Million

191

56.2M

499K

637K

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.03B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.